STAT3 and chondrosarcoma: Other promising treatments include MLN4924, a NEDD8-activating enzyme inhibitor, which has shown antitumor effects in both cell lines and a xenograft mouse model [80], and resveratrol, which inhibited cell viability and suppressed the STAT3 signaling pathway in chondrosarcoma cells [81].